Zobrazeno 1 - 10
of 237
pro vyhledávání: '"Methionine-choline deficient diet"'
Publikováno v:
Frontiers in Nutrition, Vol 10 (2023)
Background and purposeSilibinin (SIL) is a flavonoid lignin isolated from the fruit and seeds of silybum marianum that exhibits good therapeutic potential for NASH. However, the effects of SIL on serum lipids, bile acids (BAs), and gut microbiota (GM
Externí odkaz:
https://doaj.org/article/1ae2e0c3ad0245bbad95d4b25030aebc
Autor:
Yuka Yoshino, Yuta Fujii, Kazuhiro Chihara, Aya Nakae, Jun-ichiro Enmi, Yoshichika Yoshioka, Izuru Miyawaki
Publikováno v:
Toxicology Reports, Vol 10, Iss , Pp 481-486 (2023)
No method of monitoring drug-induced hepatic steatosis has been established, which is a concern in drug development. Hepatic steatosis is divided into diffuse and non-diffuse forms according to the pattern of fat deposition. Diffuse hepatic steatosis
Externí odkaz:
https://doaj.org/article/a62356ed7679451786ca40cbc0c7c706
Autor:
Jie Tong, Dongjie Li, Hongbo Meng, Diyang Sun, Xiuting Lan, Min Ni, Jiawei Ma, Feiyan Zeng, Sijia Sun, Jiangtao Fu, Guoqiang Li, Qingxin Ji, Guoyan Zhang, Qirui Shen, Yuanyuan Wang, Jiahui Zhu, Yi Zhao, Xujie Wang, Yi Liu, Shenxi Ouyang, Chunquan Sheng, Fuming Shen, Pei Wang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 12, Iss 9, Pp 3650-3666 (2022)
Metabolic-associated fatty liver disease (MAFLD), which is previously known as non-alcoholic fatty liver disease (NAFLD), represents a major health concern worldwide with limited therapy. Here, we provide evidence that ferroptosis, a novel form of re
Externí odkaz:
https://doaj.org/article/1de63aacd7f24efe97e8f991e9363c6b
Autor:
Xinxue Wang, Jia Luo, Zhuoheng Lu, Shenzhe Fang, Mengxia Sun, Wenjing Luo, Jianwei Shen, Aiming Liu, Hua Ye
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver diseases. In most cases, NAFLD progresses from benign steatosis to steatohepatitis (NASH), and then to cirrhosis. No treatment is currently approved for NAFLD
Externí odkaz:
https://doaj.org/article/d585dbe5b646497084176bd16ce0baf1
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 3, p 1390 (2024)
Non-alcoholic steatohepatitis (NASH) is an inflammatory form of non-alcoholic fatty liver disease (NAFLD), closely associated with disease progression, cirrhosis, liver failure, and hepatocellular carcinoma. Time-restricted feeding (TRF) has been sho
Externí odkaz:
https://doaj.org/article/29347079c5914612951e8474885b6fbd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tariq Jamal Khan, Xiaofei Xu, Xiaoling Xie, Ximing Dai, Pingnan Sun, Qingdong Xie, Xiaoling Zhou
Publikováno v:
Current Issues in Molecular Biology, Vol 44, Iss 3, Pp 1224-1234 (2022)
Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disorder characterized by an enhanced accumulation of lipids, which affects around 40% of the world’s population. The T. fuciformis fungus possesses immunomodulatory activity and other ben
Externí odkaz:
https://doaj.org/article/32f53a615e3a4d62b76d7dd90769b61f
Autor:
Mariana Silva Thomaz, Marcela Nascimento Sertorio, Marcos Leoni Gazarini, Daniel Araki Ribeiro, Luciana Pellegrini Pisani, Marcia Regina Nagaoka
Publikováno v:
Biomedicines, Vol 11, Iss 8, p 2199 (2023)
Non-alcoholic fatty liver is the leading cause of hepatic disease worldwide and ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) due to cell injury, oxidative stress, and apoptosis. The kinins’ role in the liver has been studied
Externí odkaz:
https://doaj.org/article/67ca996825d54d87a9ec67082ff54f86
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 151, Iss , Pp 113076- (2022)
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease that may progress to nonalcoholic steatohepatitis (NASH), hepatic tissue fibrosis, liver cirrhosis, and hepatocellular carcinoma. In this study, we investigated the effects of
Externí odkaz:
https://doaj.org/article/c7badbeb7a1e4902b106c31a4611faa9
Publikováno v:
Antioxidants, Vol 12, Iss 1, p 9 (2022)
Non-alcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver disease worldwide. In addition, NAFLD may increase the risk of cardiovascular and liver-related diseases, and displays features of metabolic syndrome. In NAFLD, ox
Externí odkaz:
https://doaj.org/article/9706cae8b5e248e890dabfd228e6c5d7